About Imophoron
Imophoron is a company based in Bristol (United Kingdom) founded in 2017. Imophoron has raised $1.01 million across 2 funding rounds. The company has 11 employees as of December 31, 2023. Imophoron operates in a competitive market with competitors including Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
- Headquarter Bristol, United Kingdom
- Employees 11 as on 31 Dec, 2023
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Imophoron Limited
- Date of Incorporation 05 Dec, 2017
- Jurisdiction BRISTOL, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.01 M (USD)
in 2 rounds
-
Latest Funding Round
$506.76 K (USD), Seed
Jun 14, 2023
-
Investors
Not available
-
Employee Count
11
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Imophoron
Unlock access to complete
Unlock access to complete
Funding Insights of Imophoron
Imophoron has successfully raised a total of $1.01M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $506.76 thousand completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Imophoron
Investment portfolio details for Imophoron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Imophoron
Detailed financials for Imophoron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Imophoron Comparisons
Peer comparison for Imophoron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Imophoron
Imophoron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neovacs, Intravacc, Fina Biosolutions, Yapanbio and VERAXA, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine manufacturing services are provided by Neovacs CDMO.
|
|
| Locked | Locked | Locked |
Vaccine development services for bacterial and viral vaccines are provided.
|
|
| Locked | Locked | Locked |
Biotechnology company specializing in bioconjugation services mainly for vaccine development
|
|
| Locked | Locked | Locked |
Contract manufacturing of bio-therapeutics and vaccines is provided.
|
|
| Locked | Locked | Locked |
Antibody therapeutics for cancer treatment are developed via microfluidic screening.
|
|
| Locked | Locked | Locked |
New molecules are discovered, developed, and manufactured in biotechnology.
|
Detailed competitors of Imophoron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Imophoron
Complete news archive for Imophoron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imophoron
Imophoron was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Imophoron is headquartered in Bristol, United Kingdom. It is registered at Bristol, England, United Kingdom.
Imophoron is a funded company, having raised a total of $1.01M across 2 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Imophoron is 11.
Imophoron was founded in 2017 in Bristol, United Kingdom, operating as a contract development and manufacturing organization in the biotechnology sector. Vaccine production services are provided for diseases including respiratory syncytial virus, COVID, and Chikungunya. A specialized platform is developed to address existing infectious threats and potential future pathogens, supporting global health needs through targeted manufacturing capabilities.